Hologic, Inc. (HOLX)
USD 71.47
(-1.09%)
USD 71.47
(-1.09%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 2.49 Billion USD | -1.35% |
| 2023 | 2.53 Billion USD | -9.87% |
| 2022 | 2.8 Billion USD | 3.55% |
| 2021 | 2.71 Billion USD | -0.06% |
| 2020 | 2.71 Billion USD | -2.5% |
| 2019 | 2.78 Billion USD | 2.92% |
| 2018 | 2.7 Billion USD | 24.52% |
| 2017 | 2.17 Billion USD | -28.77% |
| 2016 | 3.04 Billion USD | -6.11% |
| 2015 | 3.24 Billion USD | -21.8% |
| 2014 | 4.15 Billion USD | -2.1% |
| 2013 | 4.24 Billion USD | -14.67% |
| 2012 | 4.97 Billion USD | 233.95% |
| 2011 | 1.48 Billion USD | 2.87% |
| 2010 | 1.44 Billion USD | -22.41% |
| 2009 | 1.86 Billion USD | -13.76% |
| 2008 | 2.16 Billion USD | 23348.49% |
| 2007 | 9.22 Million USD | 49.63% |
| 2006 | 6.16 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 472 Thousand USD | -69.55% |
| 2003 | 1.55 Million USD | -31.66% |
| 2002 | 2.26 Million USD | -92.02% |
| 2001 | 28.41 Million USD | 13.66% |
| 2000 | 25 Million USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | -100.0% |
| 1989 | 1 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 2.5 Billion USD | -0.34% |
| 2024 Q4 | 2.49 Billion USD | -0.34% |
| 2024 Q2 | 2.51 Billion USD | -0.34% |
| 2024 Q1 | 2.53 Billion USD | -0.34% |
| 2023 Q3 | 2.78 Billion USD | -0.3% |
| 2023 Q2 | 2.79 Billion USD | -0.3% |
| 2023 Q1 | 2.8 Billion USD | -0.08% |
| 2023 FY | 2.53 Billion USD | -9.87% |
| 2023 Q4 | 2.53 Billion USD | -9.25% |
| 2022 FY | 2.8 Billion USD | 3.55% |
| 2022 Q3 | 2.83 Billion USD | 0.0% |
| 2022 Q4 | 2.8 Billion USD | -0.89% |
| 2022 Q2 | 2.83 Billion USD | -0.26% |
| 2022 Q1 | 2.84 Billion USD | 4.75% |
| 2021 Q1 | 2.7 Billion USD | -0.28% |
| 2021 Q2 | 2.69 Billion USD | -0.39% |
| 2021 Q4 | 2.71 Billion USD | 1.29% |
| 2021 Q3 | 2.67 Billion USD | -0.67% |
| 2021 FY | 2.71 Billion USD | -0.06% |
| 2020 Q1 | 2.78 Billion USD | 0.17% |
| 2020 Q2 | 2.76 Billion USD | -0.74% |
| 2020 Q3 | 2.74 Billion USD | -0.67% |
| 2020 Q4 | 2.71 Billion USD | -1.28% |
| 2020 FY | 2.71 Billion USD | -2.5% |
| 2019 Q4 | 2.78 Billion USD | -0.98% |
| 2019 FY | 2.78 Billion USD | 2.92% |
| 2019 Q2 | 2.81 Billion USD | -0.3% |
| 2019 Q1 | 2.82 Billion USD | 4.58% |
| 2019 Q3 | 2.81 Billion USD | -0.3% |
| 2018 FY | 2.7 Billion USD | 24.52% |
| 2018 Q2 | 2.76 Billion USD | -0.68% |
| 2018 Q4 | 2.7 Billion USD | -1.41% |
| 2018 Q3 | 2.74 Billion USD | -0.64% |
| 2018 Q1 | 2.78 Billion USD | 27.99% |
| 2017 Q4 | 2.17 Billion USD | -2.63% |
| 2017 FY | 2.17 Billion USD | -28.77% |
| 2017 Q1 | 2.61 Billion USD | -14.23% |
| 2017 Q2 | 2.25 Billion USD | -13.69% |
| 2017 Q3 | 2.23 Billion USD | -1.18% |
| 2016 Q4 | 3.04 Billion USD | -1.28% |
| 2016 Q3 | 3.08 Billion USD | -0.3% |
| 2016 Q2 | 3.09 Billion USD | -4.36% |
| 2016 Q1 | 3.23 Billion USD | -0.27% |
| 2016 FY | 3.04 Billion USD | -6.11% |
| 2015 Q4 | 3.24 Billion USD | -0.7% |
| 2015 FY | 3.24 Billion USD | -21.8% |
| 2015 Q2 | 3.35 Billion USD | -11.99% |
| 2015 Q3 | 3.27 Billion USD | -2.6% |
| 2015 Q1 | 3.81 Billion USD | -8.13% |
| 2014 Q1 | 4.22 Billion USD | -1.19% |
| 2014 Q2 | 4.18 Billion USD | -0.97% |
| 2014 Q3 | 4.16 Billion USD | -0.37% |
| 2014 FY | 4.15 Billion USD | -2.1% |
| 2014 Q4 | 4.15 Billion USD | -0.37% |
| 2013 Q3 | 4.34 Billion USD | -4.48% |
| 2013 Q1 | 4.23 Billion USD | -14.77% |
| 2013 Q2 | 4.55 Billion USD | 7.41% |
| 2013 Q4 | 4.27 Billion USD | -1.65% |
| 2013 FY | 4.24 Billion USD | -14.67% |
| 2012 Q4 | 4.97 Billion USD | 222.35% |
| 2012 FY | 4.97 Billion USD | 233.95% |
| 2012 Q3 | 1.54 Billion USD | 0.99% |
| 2012 Q2 | 1.52 Billion USD | 1.29% |
| 2012 Q1 | 1.5 Billion USD | 1.27% |
| 2011 Q2 | 1.45 Billion USD | 1.24% |
| 2011 Q1 | 1.43 Billion USD | -0.89% |
| 2011 Q3 | 1.47 Billion USD | 1.26% |
| 2011 FY | 1.48 Billion USD | 2.87% |
| 2011 Q4 | 1.48 Billion USD | 1.26% |
| 2010 Q1 | 1.48 Billion USD | -20.51% |
| 2010 Q2 | 1.41 Billion USD | -4.85% |
| 2010 Q3 | 1.42 Billion USD | 1.29% |
| 2010 Q4 | 1.44 Billion USD | 1.29% |
| 2010 FY | 1.44 Billion USD | -22.41% |
| 2009 Q4 | 1.86 Billion USD | -5.87% |
| 2009 FY | 1.86 Billion USD | -13.76% |
| 2009 Q2 | 2.08 Billion USD | -2.51% |
| 2009 Q1 | 2.13 Billion USD | -1.29% |
| 2009 Q3 | 1.98 Billion USD | -4.78% |
| 2008 Q4 | 2.16 Billion USD | 24.64% |
| 2008 FY | 2.16 Billion USD | 23348.49% |
| 2008 Q3 | 1.73 Billion USD | -4.93% |
| 2008 Q1 | 2.03 Billion USD | 21952.42% |
| 2008 Q2 | 1.82 Billion USD | -10.27% |
| 2007 Q2 | 7.02 Million USD | 20.08% |
| 2007 Q3 | 7.06 Million USD | 0.6% |
| 2007 FY | 9.22 Million USD | 49.63% |
| 2007 Q4 | 9.22 Million USD | 30.55% |
| 2007 Q1 | 5.84 Million USD | -5.11% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | 7.92 Million USD | 0.0% |
| 2006 FY | 6.16 Million USD | 0.0% |
| 2006 Q4 | 6.16 Million USD | -22.21% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | 118 Thousand USD | -50.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q1 | 354 Thousand USD | -25.0% |
| 2005 Q2 | 236 Thousand USD | -33.33% |
| 2004 Q1 | 827 Thousand USD | -46.65% |
| 2004 FY | 472 Thousand USD | -69.55% |
| 2004 Q4 | 472 Thousand USD | -20.0% |
| 2004 Q3 | 590 Thousand USD | -16.67% |
| 2004 Q2 | 708 Thousand USD | -14.39% |
| 2003 Q3 | 1.61 Million USD | -11.66% |
| 2003 Q2 | 1.82 Million USD | -10.44% |
| 2003 Q1 | 2.04 Million USD | -10.05% |
| 2003 Q4 | 1.55 Million USD | -3.97% |
| 2003 FY | 1.55 Million USD | -31.66% |
| 2002 Q1 | 28.05 Million USD | -1.28% |
| 2002 Q4 | 2.26 Million USD | -91.76% |
| 2002 Q3 | 27.53 Million USD | -0.75% |
| 2002 FY | 2.26 Million USD | -92.02% |
| 2002 Q2 | 27.73 Million USD | -1.11% |
| 2001 Q2 | 25 Million USD | 0.0% |
| 2001 FY | 28.41 Million USD | 13.66% |
| 2001 Q4 | 28.41 Million USD | 7.03% |
| 2001 Q3 | 26.55 Million USD | 6.2% |
| 2001 Q1 | 25 Million USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | 25 Million USD | 0.0% |
| 2000 FY | 25 Million USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q1 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 FY | - USD | -100.0% |
| 1989 Q4 | 1 Million USD | 0.0% |
| 1989 FY | 1 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | -3218.229% |
| AngioDynamics, Inc. | 3.93 Million USD | -63294.263% |
| AtriCure, Inc. | 60.59 Million USD | -4021.103% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | -4031.809% |
| BioLife Solutions, Inc. | 18.31 Million USD | -13537.158% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 1.058% |
| Daxor Corporation | 755.65 Thousand USD | -330353.286% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -51578.394% |
| Femasys Inc. | 4.25 Million USD | -58542.438% |
| GlucoTrack, Inc. | 196 Thousand USD | -1273930.612% |
| Harvard Bioscience, Inc. | 30.7 Million USD | -8032.817% |
| ICU Medical, Inc. | 1.57 Billion USD | -58.268% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 3141.535% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -68258.955% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | -14921.054% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | -186.463% |
| Microbot Medical Inc. | 40 Thousand USD | -6242650.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -54379255.401% |
| Merit Medical Systems, Inc. | 823.01 Million USD | -203.41% |
| Nephros, Inc. | 1.39 Million USD | -179547.482% |
| NovoCure Limited | 596.24 Million USD | -318.806% |
| NEXGEL, Inc. | 513 Thousand USD | -486664.133% |
| NEXGEL, Inc. | 513 Thousand USD | -486664.133% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | -3598.093% |
| OraSure Technologies, Inc. | 11.38 Million USD | -21827.468% |
| Pro-Dex, Inc. | 7.53 Million USD | -33035.616% |
| Pulse Biosciences, Inc. | 8.08 Million USD | -30781.771% |
| Predictive Oncology Inc. | 2.18 Million USD | -113976.014% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -128751.324% |
| QuidelOrtho Corporation | 2.27 Billion USD | -9.792% |
| Repligen Corporation | 510.14 Million USD | -389.49% |
| Sanara MedTech Inc. | 9.11 Million USD | -27301.144% |
| STAAR Surgical Company | 31.46 Million USD | -7835.615% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -846374.576% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | -39.037% |
| Jin Medical International Ltd. | - USD | -Infinity% |